ARTELO BIOSCIENCES, INC.

ARTL

ARTELO BIOSCIENCES, INC.

ARTL

Insider Sentiment (TTM):

Last Purchase:2022-08-12Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:46,492Shares Outstanding:673,008Institutional Ownership Pct.:6.91%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	4	10	1	2	2	1	2	4	1	1	3	3
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	1	1	1	1
Available For Sale Securities Debt Securities Curr…	-	-	-	-	-	-	-	-	-	-	0	0
Assets Current
Assets Current	4	10	1	2	2	1	3	5	6	8	11	13
Deferred Costs	-	-	-	-	-	0	-	-	-	-	-	-
Marketable Securities	-	-	-	-	-	-	0	1	5	6	8	10
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	2	2	2	2	2	2	2	2	2	2	2	2
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0
Finite Lived Intangible Assets Net	-	-	-	-	-	-	-	-	-	-	2	-
Assets	6	13	3	4	4	4	5	7	8	10	13	15
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current	1	4	3	4	5	3	2	1	1	1	1	1
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current
Liabilities Current	1	6	4	5	6	3	2	1	1	1	1	1
Convertible Notes Payable	-	-	-	-	1	-	-	-	-	-	-	-
Accrued Liabilities Current	0	0	0	0	0	-	0	-	-	-	-	-
Convertible Notes Payable Current	0	0	0	1	-	-	0	-	-	-	-	-
Derivative Liabilities Current	-	1	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability	-	-	-	-	-	-	-	-	0	0	-	0
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	-	-	0	-
Liabilities	1	6	4	5	6	3	2	1	1	1	1	1
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	5	7	-1	-1	-1	1	3	6	7	10	12	15
Additional Paid In Capital	74	73	62	58	55	53	53	53	53	53	52	52
Retained Earnings Accumulated Deficit	-68	-66	-63	-59	-56	-53	-50	-46	-45	-43	-40	-37
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Liabilities And Stockholders Equity	6	13	3	4	4	4	5	7	8	10	13	15
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Debt Securities Available For Sale Amortized Cost …	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	167	167	500	500	8	50	500	50	50	50	50	50
Common Stock Shares Issued	4	1	1	1	0	0	0	0	0	0	0	0
Shares Outstanding	1	1	1	1	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-41.03%	-52.56%	-67.09%	-	-	-	2.22%	-29.44%	-5.00%	104.36%	13.85%	-52.82%
2025	8.74%	62.62%	65.05%	-55.48%	-53.70%	-69.40%	4.79%	-6.84%	2.56%	-6.00%	4.00%	-4.70%
2024	7.54%	2.69%	3.08%	-7.69%	-14.23%	-11.54%	10.24%	17.32%	7.87%	-12.68%	-5.71%	-9.03%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.00	1.79	0.17	0.38	0.39	0.49	1.44	7.15	6.56	11.36	8.51	14.58
Quick Ratio	2.89	1.76	0.15	0.35	0.36	0.42	1.32	6.97	5.96	10.55	8.08	13.97
Working Capital	2.92M	4.59M	-3.35M	-3.03M	-3.48M	-1.42M	785.00K	4.29M	5.23M	7.47M	9.69M	12.51M
Leverage & Debt
Debt to Equity	0.29	0.88	-3.20	-7.74	-4.10	4.39	0.64	0.12	0.14	0.09	0.11	0.06
Interest Coverage TTM	-47.52	-39.38	-56.99	-47.07	-70.19	-131.53	-134.44	-	-	-	-	-
Debt Ratio	0.23	0.47	1.45	1.15	1.32	0.81	0.39	0.11	0.12	0.08	0.10	0.06
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-4.75	-18.50	-38.16	-45.04	-51.45	-47.82	-51.12	-44.46	-51.80	-47.60	-49.50	-62.26
Free Cash Flow Per Share TTM	-2.03	-4.10	-5.95	-7.84	-35.56	-63.06	-67.88	-62.86	-45.76	-43.31	-39.57	-38.18
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	31.07%	51.28%	43.04%	48.19%	5.78%	6.90%	12.40%	-21.86%	-7.87%	-22.67%	-24.14%	9.79%
EPS Growth (1Y)	-92.65%	-68.52%	-59.78%	-48.74%	-19.20%	5.16%	5.27%	-23.44%	-18.49%	-31.58%	-32.07%	-0.85%
Valuation Metrics
P/E TTM	-0.36	-0.49	-0.19	-0.60	-0.95	-0.32	-0.39	-0.45	-0.47	-0.57	-0.55	-0.45
P/B TTM	0.94	1.00	-1.94	-11.28	-6.65	4.40	1.26	0.57	0.59	0.50	0.38	0.32
Market Cap	4.69M	6.64M	2.46M	7.14M	9.35M	2.87M	3.61M	3.62M	4.33M	4.78M	4.46M	4.62M
Enterprise Value	493.01K	-3.16M	2.30M	6.29M	7.28M	2.13M	1.27M	-741.61K	3.44M	3.58M	1.65M	1.98M
Calculated Values
Free Cash Flow TTM	-8.52M	-3.60M	-4.00M	-4.06M	-8.35M	-11.50M	-12.84M	-11.27M	-8.21M	-7.77M	-7.01M	-6.71M
Net Debt	-4.20M	-9.80M	-163.00K	-845.00K	-2.07M	-746.00K	-2.34M	-4.36M	-881.00K	-1.20M	-2.82M	-2.64M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-08-12Purchase

Owner: Gorgas, Gregory D.

Title: Pres, CEO, CFO, Treas & Secr

Shares: 1,200

Price/Share: $4.00

Value: $4,800.00

Shares Owned: 2,400

Relationship: Director,Officer

Ownership: Indirect

2022-08-11Purchase

Owner: Gorgas, Gregory D.

Title: Pres, CEO, CFO, Treas & Secr

Shares: 1,200

Price/Share: $4.03

Value: $4,836.00

Shares Owned: 1,200

Relationship: Director,Officer

Ownership: Indirect

2021-04-16Purchase

Owner: Gorgas, Gregory D.

Title: Pres, CEO, CFO, Treas & Secr

Shares: 8,500

Price/Share: $1.15

Value: $9,775.00

Shares Owned: 270,676

Relationship: Director,Officer

Ownership: Direct

2020-05-15Purchase

Owner: Gorgas, Gregory D.

Title: Pres, CEO, CFO, Treas & Secr

Shares: 4,200

Price/Share: $1.21

Value: $5,082.00

Shares Owned: 262,176

Relationship: Director,Officer

Ownership: Direct

2020-05-04Purchase

Owner: Matsui, Connie

Title: -

Shares: 41,667

Price/Share: $1.20

Value: $50,000.40

Shares Owned: 56,667

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-08-12	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Indirect	Purchase	1,200	4.00	$4,800.00	2,400	4
2022-08-11	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Indirect	Purchase	1,200	4.03	$4,836.00	1,200	4
2021-04-16	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	8,500	1.15	$9,775.00	270,676	4
2020-05-15	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	4,200	1.21	$5,082.00	262,176	4
2020-05-04	Matsui, Connie	Director	-	Direct	Purchase	41,667	1.20	$50,000.40	56,667	4
2020-05-04	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	4,167	1.20	$5,000.40	257,976	4
2019-11-04	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	2,400	2.21	$5,304.00	253,809	4
2019-11-01	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	2,500	2.28	$5,700.00	251,409	4
2019-10-15	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	2,600	2.05	$5,330.00	243,809	4
2019-10-11	Gorgas, Gregory D.	Director,Officer	Pres, CEO, CFO, Treas & Secr	Direct	Purchase	2,700	1.96	$5,292.00	241,209	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.91%

Inst. Shares: 46,492

Shares Outstanding: 673,008

2025-12-31

4.04%

Inst. Shares: 81,656

Shares Outstanding: 2,018,746

2025-09-30

2.12%

Inst. Shares: 33,042

Shares Outstanding: 1,555,493

2025-06-30

2.35%

Inst. Shares: 16,587

Shares Outstanding: 704,425

2025-03-31

15.83%

Inst. Shares: 86,586

Shares Outstanding: 546,948

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	46,492	673,008	6.91%
2025-12-31	81,656	2,018,746	4.04%
2025-09-30	33,042	1,555,493	2.12%
2025-06-30	16,587	704,425	2.35%
2025-03-31	86,586	546,948	15.83%
2024-12-31	34,519	567,582	6.08%
2024-09-30	22,587	538,058	4.20%
2024-06-30	25,731	538,058	4.78%
2024-03-31	24,847	538,058	4.62%
2023-12-31	24,661	531,599	4.64%
2023-09-30	22,225	527,164	4.22%
2023-06-30	39,265	476,043	8.25%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ARTELO BIOSCIENCES, INC. (ARTL) — SEC Financial Statements & Analysis

ARTELO BIOSCIENCES, INC. (ARTL) is a pharmaceutical preparations company, incorporated in NV. ARTELO BIOSCIENCES, INC. trades on Nasdaq as: ARTL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ARTELO BIOSCIENCES, INC. reported a Debt-to-Equity ratio of 0.29x, a Price-to-Book (P/B) ratio of 0.94x (TTM), at a market cap of $4.69M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.29x
P/B TTM: 0.94x
Market Cap: $4.69M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ARTELO BIOSCIENCES, INC. in?

ARTELO BIOSCIENCES, INC. (ARTL) operates in the Pharmaceutical Preparations industry.

What is ARTL's market cap?

ARTELO BIOSCIENCES, INC. (ARTL) has a market capitalization of $4.69M as of 2026-06-30.

What exchange does ARTL trade on?

ARTELO BIOSCIENCES, INC. (ARTL) trades on the Nasdaq.

Where is ARTELO BIOSCIENCES, INC. incorporated?

ARTELO BIOSCIENCES, INC. is incorporated in NV.